Global expansion is here for the vaccine that's months away from a regulatory approval.
News & Analysis: Takeda Pharmaceutical Company
The results provide more justification for the FDA to grant the substance emergency use authorization.
They might not have the most hyped COVID-19 programs. But they do sport the juiciest dividends.
Antibodies of recovered patients can help treat people who are infected with the novel coronavirus.
TAK earnings call for the period ending March 31, 2020.
CSL Behring and Takeda Pharmaceutical Are Leading a Coalition to Develop a COVID-19 Hyperimmune Therapy
Six companies will work together to develop a plasma-derived antibody product to fight SARS-CoV-2.
The plasma of people who have recovered from the novel coronavirus contains antibodies that could help current patients fight the infection.
The plasma of those who have recovered contains antibodies to the novel coronavirus, which could help other patients fight it off.
Forget vaccines or antivirals -- antibodies from patients who have recovered could be the secret to beating COVID-19.
The battle to defeat the coronavirus will be won. But victory won't come as quickly as anyone would like.